-
公开(公告)号：EP0938571A1
公开(公告)日：1999-09-01
申请号：EP97948802.0
申请日：1997-10-24
申请人： Novartis AG , University of Lausanne , Swiss Institute for Allergy and Asthma Research , INSTITUT SUISSE DE RECHERCHES EXPERIMENTALES SUR LE CANCER ISREC
CPC分类号： C07K14/78 , C07K19/00 , C07K2319/00 , C07K2319/21 , C07K2319/73 , C12N15/62
摘要： The present invention concerns an oligomer comprising more than 2 units, wherein each unit comprises a peptidic domain capable of oligomerizing and a domain capable of binding to an acceptor (ligand), wherein the oligomerizing domain is not an antibody or a functional antibody fragment from the constant region. Also described is the use and synthesis of this oligomer.
-
公开(公告)号：EP0938571B1
公开(公告)日：2008-05-07
申请号：EP97948802.0
申请日：1997-10-24
申请人： Novartis AG , University of Lausanne , Swiss Institute for Allergy and Asthma Research , INSTITUT SUISSE DE RECHERCHES EXPERIMENTALES SUR LE CANCER ISREC , Novartis Pharma GmbH
CPC分类号： C07K14/78 , C07K19/00 , C07K2319/00 , C07K2319/21 , C07K2319/73 , C12N15/62
摘要： The present invention concerns an oligomer comprising more than 2 units, wherein each unit comprises a peptidic domain capable of oligomerizing and a domain capable of binding to an acceptor (ligand), wherein the oligomerizing domain is not an antibody or a functional antibody fragment from the constant region. Also described is the use and synthesis of this oligomer.
-
公开(公告)号：EP0938571B8
公开(公告)日：2008-07-02
申请号：EP97948802.0
申请日：1997-10-24
申请人： University of Lausanne , Swiss Institute for Allergy and Asthma Research , INSTITUT SUISSE DE RECHERCHES EXPERIMENTALES SUR LE CANCER ISREC , Novartis Pharma GmbH
CPC分类号： C07K14/78 , C07K19/00 , C07K2319/00 , C07K2319/21 , C07K2319/73 , C12N15/62
-
-
搜索结果
3 条记录 (耗时 0.017 秒)
